CpG island hypermethylation of the RAS effector protein RASSF1A is found in the majority of NB tumours at all clinical stages [146–149] and is not associated with prognostic factors such as MYCN status or age at diagnosis [148,150]. Here, RASSF1 is linked to neuroblastoma.